One of the latest terms to emerge in aesthetics is “skin longevity”, the idea of extending the skin's healthspan or “skinspan” so that it remains healthy, resilient, and youthful over time. Rather than using reactive, "anti-ageing" quick fixes, skin longevity focuses on skin health and preserving cellular function, with patients seeking improved texture and “glow”, stronger barrier function and long-term skin quality over volume and wrinkle reduction.
But while skin health treatments may often be seen as “lighter” and less invasive than some traditional aesthetic procedures, they are not without risk.
Every treatment that disrupts the skin barrier, introduces a needle or alters the skin's healing response carries the potential for complications, patient dissatisfaction and, in some cases, insurance claims. Understanding those risks is just as important as understanding the treatment itself.
The term "skin health" now covers a wide range of clinical treatments. Optimal skin health relies on a strong, hydrated protective barrier rather than on feature correction or line-chasing. As such, treatments for skin health optimisation often sit in the regenerative category, with newer treatments such as polynucleotides proving popular alongside skin booster injectables, chemical peels, microneedling, and prescription or medical-grade skincare.
While many of these treatments are categorised as non-invasive, they are not risk-free.
Chemical peels remain a cornerstone of skin rejuvenation. By creating controlled injury to encourage cellular renewal, they can improve pigmentation, acne, scarring and signs of ageing. As peel depth increases, so does the potential for complications such as prolonged inflammation, infection, scarring and post-inflammatory hyperpigmentation.
Microneedling and radiofrequency microneedling work by stimulating the body's wound-healing response to encourage collagen production. While generally well tolerated, both treatments rely on good infection control procedures and appropriate patient selection.
Skin booster injectables have become increasingly popular for improving hydration and skin quality. Although they are often used differently to traditional dermal fillers, they remain injectable treatments and carry many of the same risks associated with needles and facial anatomy.
Regenerative treatments, including polynucleotide therapies, are another rapidly growing area. Interest in these treatments continues to rise as practitioners adopt more regenerative approaches to skin quality. Although early evidence is encouraging, research is still developing and practitioners should take care not to overstate likely outcomes during consultations.
Prescription and medical-grade skincare also forms part of many skin health treatment plans. While topical medicines can deliver significant benefits, they introduce an additional prescribing responsibility and a different regulatory pathway that practitioners should understand.
From an insurance perspective, many skin health claims have less to do with the treatment itself and more to do with assessment, communication and managing expectations.
Chemical peels require careful assessment of skin type before treatment. The depth of peel selected should be appropriate for both the patient's concerns and their skin characteristics. Assessing Fitzpatrick skin type is particularly important, as patients with darker skin tones may have a higher risk of post-inflammatory hyperpigmentation following aggressive treatment. Choosing the appropriate treatment strength and preparing patients for realistic healing times can significantly reduce avoidable complications.
Microneedling carries a different set of considerations. Devices that are not used or maintained correctly can increase the risk of cross-contamination and infection. Good infection prevention protocols, appropriate skin preparation and single-use sterile components, where required, all play an important role in reducing risk.
Injectable skin treatments require the same respect for facial anatomy as any other injectable procedure. Although skin boosters are designed differently from volumising dermal fillers, vascular compromise remains a recognised complication. Appropriate training, anatomical knowledge and the ability to recognise and manage complications remain essential.
Regenerative treatments, such as polynucleotides, represent one of the fastest-growing areas of aesthetic practice. While treatments like PRP have been used for many years, the evidence base behind newer treatments is still evolving, making it particularly important to have balanced discussions about likely outcomes and the current level of clinical evidence. Patients should understand that results can vary, that improvements are often gradual and that a course of treatment may be recommended. Clear consent, careful documentation, and realistic expectation-setting all play an important role in reducing the likelihood of complaints.
Across all skin health treatments, post-inflammatory hyperpigmentation remains one of the most common causes of patient dissatisfaction, particularly in patients with higher Fitzpatrick skin types. Thorough assessment, careful treatment selection and comprehensive pre-treatment counselling can help reduce this risk.
One of the biggest misconceptions surrounding skin health treatments is that they require less clinical assessment than injectable procedures. In reality, the same principles apply.
A comprehensive consultation should include a detailed medical history, current medications, previous aesthetic treatments and any factors that may affect wound healing or increase photosensitivity, such as retinoids, certain antibiotics or other photosensitising medicines.
Patients should also understand that many skin health treatments deliver gradual improvements rather than immediate transformation. Discussing the need for a course of treatment, maintenance sessions and realistic outcomes helps align expectations before treatment begins.
Written consent should be obtained before every procedure, supported by high-quality clinical photographythroughout the treatment journey. Good documentation provides an accurate clinical record and can become invaluable should questions arise later.
As practitioners introduce new treatments, it's equally important to review whether their insurance keeps pace with their clinical practice.
One of the most common misunderstandings is assuming that "skin treatments" are covered under a general policy. In reality, each treatment carried out should appear on your policy schedule. If you've recently completed training in a new procedure, or are planning to introduce a new treatment, it's worth checking your cover before offering it to patients.
Prescription-only skincare also follows a different liability pathway because prescribing carries additional responsibilities. If prescribing forms part of your practice, speak to Hamilton Fraser so we can advise on the appropriate level of cover.
Insurers will also expect practitioners to have appropriate qualifications and recognised training for every treatment they perform. If you're unsure whether a treatment falls within your existing policy, it's always better to ask before treating your first patient rather than after a complication has occurred.
For many clinics, skin health is becoming the foundation on which treatment plans and long-term patient relationships are built.
As treatment options continue to evolve, practitioners who combine strong clinical knowledge with thorough patient assessment, realistic communication and appropriate insurance cover will be well placed to meet growing patient demand with confidence.
For more guidance on safe aesthetic practice, explore our articles on recognising common skin conditions, taking a thorough medical history, obtaining informed patient consent and reviewing your insurance cover before introducing new treatments on the Content Hub.
Related reading
Find out how Hamilton Fraser can support you. Get an online quote for laser treatments or call us on 0800 63 43 88.
